
Tricida TCDA
Quartalsbericht 2022-Q3
hinzugefügt 16.05.2026
Tricida Langfristiger Schuldenstrom 2011-2026 | TCDA
Langfristiger Schuldenstrom Jährlich Tricida
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.74 M | 2.08 M | 1.07 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.74 M | 1.07 M | 1.96 M |
Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Cumberland Pharmaceuticals
CPIX
|
468 K | $ 6.09 | 3.71 % | $ 90.5 M | ||
|
Endo International plc
ENDP
|
956 K | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
59.5 K | - | - | $ 36.6 M | ||
|
HEXO Corp.
HEXO
|
914 K | - | 2.45 % | $ 38.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
12.5 M | - | -0.1 % | $ 2.03 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
100 K | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
1.08 M | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
343 K | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
4.36 M | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
366 K | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
634 K | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
337 K | $ 2.74 | 0.04 % | $ 1.05 B | ||
|
Athenex
ATNX
|
2.09 M | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
887 K | $ 33.77 | 2.32 % | $ 1.24 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
582 K | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
13 M | - | - | $ 11.5 B | ||
|
Pacira BioSciences
PCRX
|
8.89 M | $ 24.21 | 3.68 % | $ 1.12 B | ||
|
Eagle Pharmaceuticals
EGRX
|
1.53 M | - | -39.89 % | $ 27.7 M | ||
|
Bausch Health Companies
BHC
|
61 M | $ 5.37 | -1.83 % | $ 1.99 B | ||
|
Organogenesis Holdings
ORGO
|
4.95 M | $ 2.66 | - | $ 337 M | ||
|
Canopy Growth Corporation
CGC
|
7.46 M | $ 1.05 | 0.48 % | $ 113 M | ||
|
Solid Biosciences
SLDB
|
2.1 M | $ 6.83 | 3.17 % | $ 598 M | ||
|
Aurora Cannabis
ACB
|
5.38 M | $ 3.45 | -0.29 % | $ 189 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
58 K | $ 1.07 | -2.73 % | $ 1.33 M | ||
|
Tilray
TLRY
|
2.47 M | $ 5.42 | 2.36 % | $ 3.35 B | ||
|
Jupiter Wellness
JUPW
|
23.5 K | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
2.06 M | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
1.03 M | $ 1.13 | 0.45 % | $ 108 M | ||
|
Evolus
EOLS
|
2.53 M | $ 6.23 | 2.22 % | $ 402 M | ||
|
Sundial Growers
SNDL
|
35.5 M | $ 1.44 | -0.68 % | $ 3.37 M | ||
|
Emergent BioSolutions
EBS
|
2.4 M | $ 9.09 | 7.57 % | $ 486 M | ||
|
Veru
VERU
|
759 K | $ 2.31 | -1.7 % | $ 33.8 M | ||
|
Neoleukin Therapeutics
NLTX
|
3.05 M | - | - | $ 193 M | ||
|
Assertio Holdings
ASRT
|
240 K | $ 23.44 | - | $ 150 M | ||
|
ProPhase Labs
PRPH
|
301 K | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
613 K | - | - | $ 1.42 B | ||
|
cbdMD
YCBD
|
778 K | $ 0.74 | -3.0 % | $ 2.98 M | ||
|
PetIQ
PETQ
|
7.61 M | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
1.1 M | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
911 K | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
483 K | $ 0.71 | -2.56 % | $ 35.5 M | ||
|
PLx Pharma
PLXP
|
622 K | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
109 M | $ 16.35 | -1.77 % | $ 19 B | ||
|
Zomedica Corp.
ZOM
|
717 K | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
215 K | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
1.16 M | $ 0.77 | -3.34 % | $ 27.7 M | ||
|
China Pharma Holdings
CPHI
|
71.6 K | $ 0.76 | 0.07 % | $ 3.26 M | ||
|
TherapeuticsMD
TXMD
|
975 K | $ 2.11 | -0.47 % | $ 24.4 M |